Logo image of ACON

ACLARION INC (ACON) Stock Fundamental Analysis

NASDAQ:ACON - Nasdaq - US6551872012 - Common Stock - Currency: USD

5.11  -0.16 (-3.04%)

After market: 4.85 -0.26 (-5.09%)

Fundamental Rating

1

ACON gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 39 industry peers in the Health Care Technology industry. ACON has a bad profitability rating. Also its financial health evaluation is rather negative. ACON is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year ACON has reported negative net income.
In the past year ACON has reported a negative cash flow from operations.
ACON Yearly Net Income VS EBIT VS OCF VS FCFACON Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 -2M -4M -6M

1.2 Ratios

ACON has a Return On Assets of -191.03%. This is amonst the worse of the industry: ACON underperforms 89.19% of its industry peers.
ACON has a Return On Equity of -359.30%. This is amonst the worse of the industry: ACON underperforms 81.08% of its industry peers.
Industry RankSector Rank
ROA -191.03%
ROE -359.3%
ROIC N/A
ROA(3y)-257.22%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ACON Yearly ROA, ROE, ROICACON Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 0 500 -500

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for ACON so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
ACON Yearly Profit, Operating, Gross MarginsACON Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 -2K -4K -6K -8K -10K

More info and screens

2

2. Health

2.1 Basic Checks

ACON does not have a ROIC to compare to the WACC, probably because it is not profitable.
ACON has more shares outstanding than it did 1 year ago.
Compared to 1 year ago, ACON has a worse debt to assets ratio.
ACON Yearly Shares OutstandingACON Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2M 4M 6M
ACON Yearly Total Debt VS Total AssetsACON Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 500K 1M 1.5M 2M 2.5M

2.2 Solvency

Based on the Altman-Z score of -24.34, we must say that ACON is in the distress zone and has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of -24.34, ACON is doing worse than 91.89% of the companies in the same industry.
ACON has a Debt/Equity ratio of 0.47. This is a healthy value indicating a solid balance between debt and equity.
ACON has a Debt to Equity ratio of 0.47. This is in the lower half of the industry: ACON underperforms 64.86% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.47
Debt/FCF N/A
Altman-Z -24.34
ROIC/WACCN/A
WACC10.09%
ACON Yearly LT Debt VS Equity VS FCFACON Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 0 2M -2M -4M -6M

2.3 Liquidity

A Current Ratio of 1.28 indicates that ACON should not have too much problems paying its short term obligations.
With a Current ratio value of 1.28, ACON perfoms like the industry average, outperforming 43.24% of the companies in the same industry.
ACON has a Quick Ratio of 1.28. This is a normal value and indicates that ACON is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 1.28, ACON is in line with its industry, outperforming 43.24% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.28
Quick Ratio 1.28
ACON Yearly Current Assets VS Current LiabilitesACON Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2M 4M 6M 8M

More info and screens

2

3. Growth

3.1 Past

ACON shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 85.81%, which is quite impressive.
The Revenue for ACON has decreased by -35.17% in the past year. This is quite bad
Measured over the past years, ACON shows a quite strong growth in Revenue. The Revenue has been growing by 15.77% on average per year.
EPS 1Y (TTM)85.81%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-1644.79%
Revenue 1Y (TTM)-35.17%
Revenue growth 3Y15.77%
Revenue growth 5YN/A
Sales Q2Q%-35.74%

3.2 Future

Based on estimates for the next years, ACON will show a very negative growth in Earnings Per Share. The EPS will decrease by -1766.08% on average per year.
Based on estimates for the next years, ACON will show a very negative growth in Revenue. The Revenue will decrease by -27.54% on average per year.
EPS Next Y-71748.68%
EPS Next 2Y-1766.08%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-81.67%
Revenue Next 2Y-27.54%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
ACON Yearly Revenue VS EstimatesACON Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 2025 100K 200K 300K
ACON Yearly EPS VS EstimatesACON Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 -2K -4K -6K -8K -10K

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for ACON. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for ACON. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ACON Price Earnings VS Forward Price EarningsACON Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ACON Per share dataACON EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -20 -40 -60 -80 -100

4.3 Compensation for Growth

A cheap valuation may be justified as ACON's earnings are expected to decrease with -1766.08% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-1766.08%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

ACON does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ACLARION INC

NASDAQ:ACON (2/21/2025, 8:00:00 PM)

After market: 4.85 -0.26 (-5.09%)

5.11

-0.16 (-3.04%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)11-14 2024-11-14/dmh
Earnings (Next)N/A N/A
Inst Owners3.28%
Inst Owner Change24.04%
Ins Owners10.11%
Ins Owner Change0%
Market Cap5.21M
Analysts80
Price TargetN/A
Short Float %N/A
Short Ratio0
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)23.46%
Min EPS beat(2)22.6%
Max EPS beat(2)24.32%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-51.26%
Min Revenue beat(2)-56.98%
Max Revenue beat(2)-45.53%
Revenue beat(4)0
Avg Revenue beat(4)-67.13%
Min Revenue beat(4)-90.98%
Max Revenue beat(4)-45.53%
Revenue beat(8)2
Avg Revenue beat(8)-36.71%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)4%
EPS NQ rev (1m)-33400%
EPS NQ rev (3m)-33400%
EPS NY rev (1m)-33400%
EPS NY rev (3m)-31282.2%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-24.66%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 96.52
P/FCF N/A
P/OCF N/A
P/B 3.17
P/tB 12.83
EV/EBITDA N/A
EPS(TTM)-4.73
EYN/A
EPS(NY)-134.97
Fwd EYN/A
FCF(TTM)-5.08
FCFYN/A
OCF(TTM)-4.88
OCFYN/A
SpS0.05
BVpS1.61
TBVpS0.4
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -191.03%
ROE -359.3%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-257.22%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.02
Health
Industry RankSector Rank
Debt/Equity 0.47
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 117.61%
Cap/Sales 378.52%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.28
Quick Ratio 1.28
Altman-Z -24.34
F-Score4
WACC10.09%
ROIC/WACCN/A
Cap/Depr(3y)91.21%
Cap/Depr(5y)N/A
Cap/Sales(3y)224.5%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)85.81%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-1644.79%
EPS Next Y-71748.68%
EPS Next 2Y-1766.08%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-35.17%
Revenue growth 3Y15.77%
Revenue growth 5YN/A
Sales Q2Q%-35.74%
Revenue Next Year-81.67%
Revenue Next 2Y-27.54%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y6.21%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y26.98%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y26.31%
OCF growth 3YN/A
OCF growth 5YN/A